Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
110,630,750
-
Share change
-
-1,904,593
-
Total reported value
-
$142,714,025
-
Put/Call ratio
-
14%
-
Price per share
-
$1.29
-
Number of holders
-
115
-
Value change
-
-$2,533,807
-
Number of buys
-
38
-
Number of sells
-
56
Institutional Holders of RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) as of Q2 2023
As of 30 Jun 2023,
RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,630,750 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., Soleus Capital Management, L.P., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, Assenagon Asset Management S.A., JACOBS LEVY EQUITY MANAGEMENT, INC, and STATE STREET CORP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.